Overestimation of subclinical atherosclerosis in psoriasis

Zeinab Aryanian; Azar Shirzadian; Raheleh Mehraeen; Morteza Ashrafian Amiri; Arghavan Azizpour; Azadeh Goodarzi; Parvaneh Hatami

doi:10.1111/ced.15247

Overestimation of subclinical atherosclerosis in psoriasis

Clin Exp Dermatol. 2022 Sep;47(9):1722-1724. doi: 10.1111/ced.15247. Epub 2022 Jun 23.

Authors

Zeinab Aryanian^{1

2}, Azar Shirzadian², Raheleh Mehraeen³, Morteza Ashrafian Amiri¹, Arghavan Azizpour^{1

4}, Azadeh Goodarzi^{5

6}, Parvaneh Hatami¹

Affiliations

¹ Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
² Department of Dermatology, School of Medicine, Babol University of Medical Sciences, Bābol, Iran.
³ Department of Radiology, Beheshti University Hospital, Babol University of Medical Sciences, Bābol, Iran.
⁴ Department of Dermatology, School of Medicine, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
⁶ Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 35510302
DOI: 10.1111/ced.15247

Abstract

This study is one of a few that have been conducted to evaluate subclinical atherosclerosis in Iranian patients with psoriasis. Based on our findings, routine ultrasonography evaluation of all of patients with psoriasis does not seem to be reasonable or cost-effective.

Publication types

Letter

MeSH terms

Atherosclerosis* / complications
Atherosclerosis* / diagnostic imaging
Case-Control Studies
Humans
Iran
Psoriasis* / complications
Ultrasonography